Applied Health Economics and Health Policy

Soft Regulations in Pharmaceutical Policy Making: An Overview of Current Approaches and their Consequences
pp. 137-147(11)
Authors: Wettermark, Björn; Godman, Brian; Jacobsson, Bengt; Haaijer-Ruskamp, Flora M.

Value-Based Insurance Design in Medicare
pp. 149-154(6)
Author: Encinosa, William E.

Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
pp. 155-165(11)
Authors: Golec, Joseph; Vernon, John A.

Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study
pp. 167-180(14)
Authors: Kristiansen, Ivar Sønbø; Bingefors, Kerstin; Nyholm, Dag; Isacson, Dag

Economic Evaluation of Sinfrontal® in the Treatment of Acute Maxillary Sinusitis in Adults
pp. 181-191(11)
Authors: Kneis, Kyra C.; Gandjour, Afschin

The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK
pp. 193-205(13)
Authors: Liu, Zhimei; Doan, Quan V.; Malin, Jennifer; Leonard, Robert